
4D Pharma announces positive topline results for the treatment of asthma
4D Pharma has announced positive topline results from Part A of its Phase I/II clinical trial of MRx-4DP0004, an orally-delivered single strain Live Biotherapeutic being developed for the treatment of asthma. Part A The Phase I/II trial is a multi-center, double-blind, placebo-controlled study in patients… Read More















